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Objective:  Bidirectional links between the nervous and immune sys-
tems modulate inflammation. The cellular mechanisms underlying 
the detection of danger-associated molecular patterns and patho-
gen-associated molecular patterns by the nervous system are not 
well understood. We hypothesized that the carotid body, a tissue of 
neural crest origin, detect pathogen associated molecular patterns 
and danger associated molecular patterns via an inflammasome-
dependent mechanism similar to that described in immune cells.
Design:  Randomized, controlled laboratory investigation.
Setting:  University laboratory.
Subjects:  C57Bl/6J mice; juvenile Sprague-Dawley rats, primary 
human neutrophils.
Interventions:  Rat carotid body chemosensitive cells, and human 
neutrophils, were treated with TLR agonists to activate inflamma-
some-dependent pathways. In mice, systemic inflammation was 
induced by the pathogen associated molecular pattern zymo-
san (intraperitoneal injection; 500 mg/kg). Isolated carotid body/
carotid sinus nerve preparations were used to assess peripheral 
chemoafferent activity. Ventilation was measured by whole-body 
plethysmography.
Measurements and Main Results:  Chemosensitive carotid 
body glomus cells exhibited toll-like receptor (TLR-2 and 
TLR-4), NLRP1, and NLRP3 inflammasome immunoreactivities. 
Zymosan increased NLRP3 inflammasome and interleukin-
1β expression in glomus cells (p < 0.01). Human neutrophils 
demonstrated similar LPS-induced changes in inflammasome 
expression. Carotid body glomus cells also expressed IL-1 
receptor and responded to application of IL-1β with increases in 
intracellular [Ca2+]. Four hours after injection of zymosan carotid 
sinus nerve chemoafferent discharge assessed in vitro (i.e., in 
the absence of acidosis/circulating inflammatory mediators) 
was increased five-fold (p < 0.001). Accordingly, zymosan-
induced systemic inflammation was accompanied by enhanced 
respiratory activity.
Conclusions:  In carotid body chemosensitive glomus cells, activa-
tion of toll-like receptors increases NLRP3 inflammasome expres-
sion, and enhances IL-1β production, which is capable of acting in 
an autocrine manner to enhance peripheral chemoreceptor drive. 
(Crit Care Med 2013; 41:e85–e92)
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Inflammasomes have emerged as important cellular complexes involved in the detection of both pathogen-associated molecular patterns (PAMPs) and endog-
enous danger-associated molecular patterns (DAMPs) by 
immune cells (1). Once activated, inflammasomes assem-
ble as a cytoplasmic multiprotein complex to activate cas-
pase-1, which proteolytically converts the precursors of 
proinflammatory cytokines, pro-interleukin (IL)-1β and 
pro-IL-18 into active molecules (2). In concert with periph-
eral immune cell signaling, neural mechanisms orches-
trate the inflammatory response via autonomic-immune 
effector pathways (3). However, the mechanisms underly-
ing detection of PAMPs and DAMPs by the nervous system 
remain unclear.
The onset of critical illness is frequently accompanied by 
tachycardia and tachypnea (4). Although these physiologi-
cal features are commonplace in the critically ill, they often 
occur in the absence of systemic hypoxia, hypercapnia and/
or acidosis (5, 6), major stimuli for increased peripheral 
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chemoreceptor activity and chemoreceptor-driven cardio-
vascular and respiratory responses (7), including rapid alter-
ations in heart rate variability (8, 9). Circulating DAMPs, may 
therefore be an important additional stimulus for increasing 
peripheral chemoreceptor activity, beyond (and in addi-
tion to) previously identified cytokine mediators (10). We 
therefore hypothesized that chemosensitive glomus cells of 
the carotid body—a peripheral afferent organ of neural crest 
origin—are capable of detecting PAMPs/DAMPs by inflam-
masome activation, to relay immune/inflammatory signals 
to the central nervous system. We used the yeast cell wall 
product zymosan, which activates the NLRP3 inflamma-
some via toll-like receptor-2 (11), to produce a robust model 
of sterile systemic inflammation in vivo (12, 13) and in cul-
tured cells (12).
MATERIALS AND METHODS
All experiments were performed in accordance with the 
United Kingdom Animals (Scientific Procedures) Act (1986). 
All drugs were acquired from Sigma (Poole, UK) unless stated 
otherwise.
Carotid body Cell Cultures
Sprague-Dawley rat pups (7–11 days old; local breeding colony 
at University College London) were terminally anesthetized 
with isoflurane prior to bilateral excision of the carotid bodies 
(14). Chemosensitive glomus cells were enzymatically isolated 
by exposing the carotid body tissue to a 0.1% trypsin-0.1% 
collagenase solution for 1 hr at 37°C followed by mechanical 
dissociation. The dispersed cell suspension was then collected 
and triturated in growth medium (F-12 nutrient medium sup-
plemented with 10% (v/v) fetal bovine serum, 80 U/L insulin, 
0–6% (w/v) glucose, 2 mM glutamine and 1% penicillin-strep-
tomycin). Dispersed cells were then placed onto poly-L-lysine 
coated cover slips. Cultures were grown at 37°C in a humidified 
atmosphere of 95% air/5% CO
2
 for 72 hours. Each cell cul-
ture contained multiple cell clusters containing approximately 
5–30 chemosensitive glomus cells that were easily identified 
under bright field microscopy. To activate inflammasome-
dependent signaling pathways, cultures were incubated in a 
growth medium containing 0, 0.5, or 5 μg/mL of zymosan for 
24 hours.
Primary Human Neutrophils
Primary human neutrophils (>97% purity) were isolated 
as described previously (12) and incubated with lipo-
polysaccharide (10 ng/mL; Escherichia coli B0111:B4) or 
 phosphate-buffered saline for 1.5 hours prior to cell fixa-
tion. Lipopolysaccharide was used since previous studies have 
shown that in primary human neutrophils the NLRP3 inflam-
masome is not activated by zymosan (15).
Immunofluorescence Studies
Cell cultures were fixed with 4% paraformaldehyde solution 
and permeabilized with 0.025% Triton X-100. Blocking solu-
tion contained 1% bovine serum albumin and 10% of either 
goat or donkey normal serum. Nuclear structures were stained 
with 4′,6-diamidino-2-phenylindole (DAPI). Tyrosine hydrox-
ylase (TH) immunostaining was performed routinely to con-
firm the glomus cell phenotype. Cultures were simultaneously 
incubated with sheep anti-TH antibody (1:250 Abcam, Cam-
bridge, UK) with the addition of one of the following antibod-
ies: goat anti-TLR4 (1:500; Santa Cruz, Heidelberg, Germany), 
rabbit anti-TLR2 (1:250; Santa Cruz), goat anti-IL-1β (epitope 
mapping at the C-terminus (16, 17); 1:500; Santa Cruz); goat 
anti-IL-1ra/IL-1F3 (1:250; R & D Systems, Abingdon, UK); rab-
bit anti-NLRP1 (1:500; Abcam) and goat anti-NLRP3 (1:500, 
Abcam). Negative controls were performed by the omission of 
primary or secondary antibodies.
Confocal Microscopy Imaging
Images were captured using a Confocal Laser Scanning 
Microscope, (Zeiss 510, Welwyn Garden City, UK) with 40X 
or 60X oil-immersion objectives. UV, argon (458, 477, 488, 
504 nm), or helium-neon (543 nm, 633 nm) lasers were used 
as appropriate. All images were captured using the same 
settings to enable comparisons of fluorescence intensities 
between different cell cultures. Intensity of fluorescence was 
estimated using Zeiss LSM 510 software and expressed in 
arbitrary units (AU).
Intracellular Ca2+ Imaging
Glomus cells were loaded for 40 min at room temperature with 
Fluo-4 AM (4 μM) or Fura-2 AM (4μM) to determine changes 
in cytosolic [Ca2+] in response to hypoxia or IL-1β application.
Model of Systemic Inflammation
C57BL/6 inbred mice (~20 g; Charles River, UK) received 
intraperitoneal injections of zymosan (500 mg kg-1; n = 12) 
(12) to induce systemic inflammation or sterile saline (0.2 mL; 
controls; n = 12). Severity scores were recorded as described 
 previously (18).
Whole-body Plethysmography
Ventilation was measured in conscious, freely moving C57BL/6 
mice (Charles River, UK) injected with either zymosan or ster-
ile saline (n = 5 per group) immediately before being placed 
in a whole-body plethysmograph, as described previously (13, 
18, 19). The recording chamber (250 mL) was flushed continu-
ously with a humidified mixture of 79% nitrogen and 21% 
oxygen, at a rate of 500 mL/min with temperature maintained 
at 22°C. Levels of oxygen and carbon dioxide were monitored 
using a fast-response gas analyzer (Morgan Medical, Hertford, 
UK). Tidal volume was determined following calibration of 
the plethysmograph through repeated injections and with-
drawal of different volumes of air from within the recording 
chamber. The mice were left to acclimatize to the chamber 
environment for at least 30 minutes before measurements of 
baseline ventilation were taken. Minute ventilation was calcu-
lated from the product of respiratory frequency and tidal volume 
measurements.
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Carotid Sinus Nerve Recordings
Three hours after intraperitoneal injections of zymosan or 
sterile saline, mice were euthanized under 5% isoflurane anes-
thesia. The carotid bifurcation region was rapidly removed, 
placed into a recording chamber (~3 mL), carotid sinus nerve 
(CSN) was isolated, de-sheathed, and recordings were made 
using a suction electrode, as described previously (14, 19, 20). 
Nerve activity signal was amplified (×20,000) and filtered 
(200–3,000 Hz), with data acquired and stored using Spike2 
software (Cambridge Electronic Design Ltd, Cambridge, UK). 
Single-unit analysis was performed offline using the spike-
sorting function of Spike2 software (18). CSN chemoafferent 
activity was recorded during baseline normoxia and hypoxia, 
produced by exposure of the preparations to Krebs’ solution 
saturated with 95% N
2
/5% CO
2
 for 3 minutes. Peak CSN activ-
ity was estimated at the end of each experiment by application 
of sodium cyanide (0.03% w/v; 50 μL bolus).
Cytokine Measurements
Cytokine levels in plasma were determined using an enzyme-
linked immunosorbent assay kit (ProteoPlex Murine Cyto-
kineArray, Novagen, Germany), according to manufacturer’s 
instructions. Arterial blood samples were drawn from the 
carotid artery 3 hours after injection of zymosan. Plasma 
was separated by centrifugation and stored at −80°C until 
assayed.
Statistical Analysis
The data were analyzed using GraphPad Prism 5 software. Sta-
tistical significance was tested by Student t test for paired or 
unpaired data (two groups) or by repeated measures ANOVA 
(multiple groups) followed by Tukey-Kramer testing for mul-
tiple comparisons between groups. Mean values (±se) are pre-
sented, unless stated otherwise. Significance was accepted at p 
values of less than 0.05.
Figure 1.  Expression of inflammasome complexes in cultured carotid body glomus cells. A and B, Representative confocal images showing clusters of 
the carotid body glomus cells stained with 4′,6-diamidino-2-phenylindole and identified on the basis of tyrosine hydroxylase immunoreactivity. C and D, 
Toll-like receptor (TLR2 and TLR4) immunoreactivities in glomus cells. E and F, NLRP1 immunoreactivity in glomus cells following incubation in control 
medium (C) or in the presence of 500 ng/mL of zymosan (Z). G and H, NLRP3 immunoreactivity in glomus cells following incubation in control medium 
(C) or in the presence of 500 ng/mL of zymosan (Z). Note increased immunofluorescence levels in cultures incubated with zymosan. I and J, NLRP1 and 
NLRP3 immunoreactivities in primary human neutrophils following incubation in control medium (C) or in the presence of 10 ng/mL of lipopolysaccharide 
(L). K, Summary data showing significant increases in NLRP1 and NLRP3 immunofluorescence intensities in primary human neutrophils in response to 
lipopolysaccharide (L). L, Summary data showing significant increase in NLRP3 immunofluorescence intensity in glomus cells in response to zymosan 
(Z). Data are presented as means ± SE. *Significant difference (p < 0.05).
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RESULTS
Expression of Inflammasome Complexes in Cultured 
Chemosensitive Carotid Body Glomus Cells
We investigated the presence and changes in the expression level 
of inflammasomes in cultured chemosensitive glomus cells fol-
lowing incubation with zymosan. Carotid body glomus cells 
(Fig. 1A and B) were found to display TLR-2 (Fig. 1C), TLR-4 
(Fig. 1D), NLRP1 (Fig. 1E) and NLRP3 (Fig. 1G) inflammasome 
immunoreactivities. NLRP1 staining was found to be dispersed 
throughout the cell body (Fig. 1E). As reported previously 
(15), distribution of NLRP3 protein could be different, and 
in glomus cells being concentrated around the edge of the cell 
(Fig. 1G). NLRP3 expression by glomus cells was up- regulated 
(Fig. 1H, L; p = 0.023) following incubation with zymosan, 
whereas expression of NLRP1 was unaffected (Fig. 1F and L). 
Incubation of primary human neutrophils with lipopolysac-
charide induced similar in magnitude increases in the expres-
sion of both NLRP1 and NLRP3 inflammasomes (Fig. 1I–K).
Effect of Zymosan on IL-1β Expression in 
Chemosensitive Carotid Body Glomus Cells
Incubation of glomus cells in the presence of zymosan (0.5 
or 5 µg/mL) resulted in a profound up-regulation of IL-1β 
expression (Fig. 2A and B; p < 0.0001). We also confirmed the 
presence of IL-1 receptor immunoreactivity in glomus cells 
(Fig. 2C) suggesting that IL-1β produced by these cells may act 
in an autocrine manner.
Effect of IL-1β on [Ca2+]i in Chemosensitive Carotid 
Body Glomus Cells
Next, we confirmed that IL-1β is capable of eliciting a physi-
ological response in the carotid body glomus cells. As expected, 
hypoxia activated glomus cells, as characterized by immediate 
high amplitude increases in [Ca2+]
i
 with a rapid return to basal 
levels shortly after reoxygenation (Fig. 3A and B). In condi-
tions of normoxia, glomus cells were activated in the pres-
ence of IL-1β (n = 23 cells; three independent experiments; 
Fig. 3C and D). Application of IL-1β induced a delayed [Ca2+]
i
 
response in glomus cells, which was observed ~10 minutes after 
cytokine application and was characterized by sustained high-
amplitude oscillations in [Ca2+]
i
. IL-1β-induced Ca2+ responses 
in glomus cells were abolished in the presence of IL-1 receptor 
antagonist in the incubation media (Fig. 3E).
Carotid Body Chemoafferent Activity During Systemic 
Inflammation
Since IL-1β actions on glomus cells of the carotid body mim-
icked the effect of hypoxia, we sought in vivo evidence that sys-
temic inflammation augments carotid body chemosensitivity 
and increases ventilation. Zymosan-treated mice showed clas-
sical clinical signs of systemic inflammation, corroborated by 
high cytokine levels in plasma (Table 1). Arterial blood oxygen 
(zymosan-treated: 9.1 ± 1.6 kPa; control: 10.0 ± 1.7 kPa) and 
carbon dioxide tensions (zymosan: PaCO
2
 3.5 kPa; control: 
3.6 kPa) were similar (n = 5 each group). Developing of sys-
temic inflammation following administration of zymosan (n 
= 5) was accompanied by significant increases in respiratory 
frequency and hence minute ventilation 2 hours after the injec-
tions (p < 0.05; Fig. 4). Core temperature (34.9 ± 1.1°C) was 
lower in mice injected with zymosan (13), compared with mice 
that received sterile saline (36.2 ± 0.9°C; p < 0.05).
To determine whether zymosan-induced systemic 
inflammation alters peripheral chemoreceptor activity, we 
recorded CSN activity in a superfused in vitro carotid body/
CSN preparation free of possible confounding factors present 
in vivo such as metabolic acidosis and circulating inflammatory 
mediators. Representative examples of chemoafferent activity 
recorded in the carotid body/CSN preparations taken from the 
animals injected with saline (control) and zymosan are shown 
in Fig. 5A. Resting CSN discharge frequency was increased 
five-fold in preparations taken from zymosan-treated mice 
(p = 0.01; Fig. 5A, B). Chemoafferent responses to hypoxia 
(Fig. 5A and C) or application of cyanide (Fig. 4D) were also 
significantly enhanced in the carotid body/CSN preparations 
of mice injected with zymosan.
CSN chemoafferent activity is composed of individual spikes 
with distinguishable amplitude and shape (19). This allows 
analysis and comparison of single-unit chemoafferent activity 
between control and zymosan-treated mice. Although mean 
Figure 2.  Effects of zymosan on interleukin (IL)-1β expression in glomus 
cells of the carotid body. A, IL-1β immunoreactivity in glomus cells follow-
ing incubation in control medium (C) or in the presence of 0.5 (Z 0.5) and 
5 µg/mL (Z 5) of zymosan. B, Summary data showing significant increases 
in IL-1β immunofluorescence intensity in glomus cells in response to zymo-
san. C, IL-1 receptor immunoreactivity in glomus cells. Data are presented 
as means ± SE. * Significant difference (p < 0.05).
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discharge frequency of individual CSN fibers increased only in 
control mice during hypoxia (Fig. 6A), the overall higher CSN 
discharge in mice treated with zymosan was attributable to the 
recruitment of more individual fibers both at baseline condi-
tions and during hypoxia (p = 0.0001; Fig. 6B).
DISCUSSION
Chemosensitive glomus cells of the carotid body express 
both NLRP1 and NLRP3 inflammasomes. When stimulated 
with zymosan, glomus cells 
up-regulate the expression 
of NLRP3, suggesting that 
peripheral chemoreceptors 
of neural crest origin utilize 
the same mechanism as 
innate immune cells to detect 
PAMPs and, potentially, 
DAMPs. The data obtained 
also confirm the results of 
previous studies showing that, 
in addition to sensing arterial 
levels of PO
2
, PCO
2
, and pH, 
peripheral chemoreceptors 
are capable of detecting 
other modalities, including 
glucose concentration, various 
electrolytes, neurohormones, 
and inflammatory mediators 
(21), many of which are 
released and/or their levels 
are altered during systemic 
inflammation. Indeed, several 
groups have reported that 
various proinflammatory 
cytokines, including TNFα, 
impact on carotid body 
chemoreceptor function. 
Interestingly, experimental chronic intermittent hypoxia itself 
increases expression of proinflammatory cytokines within 
the carotid body, perhaps through oxidative stress (22). The 
generation of reactive oxygen species is crucial in regulating 
inflammasome gene expression (23). Here we extend these 
concepts by demonstrating that inflammasome complexes that 
detect an array of DAMPs regulate the expression of IL-1β by 
the chemosensitive carotid body glomus cells (24).
We have also confirmed recently reported data suggesting 
that IL-1β is a cytokine capable of altering carotid body func-
tion (25), but have extended this observation by demonstrat-
ing one of the possible sources of IL-1β as the glomus cells 
themselves following activation of TLR-2 and inflammasome 
complexes. Critically, the effects of TLR-2 receptor activation 
by zymosan were observed in an immune cell-free, aseptic 
carotid body cell culture free of many confounding factors 
such as hypoxia or inflammatory mediators. In contrast to the 
reported depressant effects of TNFα on the carotid body che-
mosensory function (26), IL-1β (given in pathophysiologically 
relevant concentrations) was found to trigger [Ca2+]
i
 oscilla-
tions in glomus cells, similar in magnitude to the responses 
elicited by hypoxia. IL-1β is known to induce expression of the 
hypoxia-inducible factor(s), which are essential for the main-
tenance of normal carotid body activity during hypoxia (27). 
Therefore, IL-1β appears to mimic the responses of the carotid 
body to hypoxia and may, therefore, act in an autocrine man-
ner to enhance the peripheral chemoreceptor drive during sys-
temic inflammation.
Figure 3.  Effects of hypoxia and IL-1β on [Ca2+]i in glomus cells of the carotid body. A, Clusters of glomus 
cells loaded with the fluorescent Ca2+ indicator Fluo-4. Fluorescent images were obtained before (left panel) 
and at the peak of [Ca2+]i response to hypoxia (right panel). B, Representative trace showing changes in [Ca
2+]i 
elicited in an individual glomus cell in response to hypoxia. C, Representative trace showing changes in [Ca2+]i 
elicited in an individual glomus cell in response to interleukin (IL)-1β. D. IL-1β-induced [Ca2+]i responses in glo-
mus cells are abolished in the presence of IL-1-receptor antagonist.
TABLE 1. Plasma Cytokine Levels in Mice 
Injected With Zymosan (500 mg/kg 
Interperitoneal)
Saline
Zymosan  
(p < 0.001)
Interleukin-1β Below 
limits of 
detection
20 ± 3
Interleukin-6 13 ± 7 3,800 ± 991
Interleukin-10 47 ± 35 382 ± 46
Tumor necrosis factor-α 112 ± 12 659 ± 189
Clinical severity score (range) 0 1–2
All values are mean ± SD (pg/mL), other than clinical severity score.
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What are the possible 
implications of inflammatory 
mediator–dependent alterations 
in the peripheral chemosensory 
function on autonomic and 
neurohormonal control? In this 
study we show that peripheral 
chemoafferent activity in normoxia 
and in conditions of hypoxia is 
markedly enhanced during early 
systemic exposure to inflammatory 
stimuli. Consistent with these 
data, chronic (proinflammatory) 
bleomycin-induced lung injury is 
accompanied by higher baseline 
respiratory rate and augmented 
hypoxic ventilatory response (28). 
The marked increase in the carotid 
body chemoafferent activity during 
early systemic inflammation implies 
that peripheral chemoreceptors may 
play a key role in the pathophysiology 
of early sepsis, perhaps by affecting 
several homeokinetic mechanisms 
that underlie biological variability. 
Carotid sinus denervation is 
associated with shorter survival time 
in rats administered lethal doses of 
endotoxin (29), although the impact 
of concomitant baro-denervation 
and consequent disruption of 
baroreflex mechanisms considerably 
complicate interpretation of any 
possible protective role of peripheral 
chemoreceptors.
Clinical data have revealed an 
association between peripheral 
chemoreflex dysfunction and out-
come from critical illness (30, 31). 
It is striking, however, that an array 
of the commonest respiratory, car-
diovascular, endocrine, and renal 
responses observed in critically ill 
patients can also be produced by 
discrete activation of the carotid 
chemoreflex (7). In addition to 
tachypnea and an increased depth 
of breathing, peripheral chemo-
receptor stimulation results in 
increased airway resistance and 
secretions (32). Release of neuro-
hormones, including cortisol and 
vasopressin, is also increased in 
response to hypoxemia and carotid 
sinus activation (5). Clinically, 
such alterations in autonomic 
Figure 4.  Zymosan-induced systemic inflammation is accompanied by increased ventilatory activity in 
mice. Group data illustrating changes in the respiratory rate (A), tidal volume (B), and minute ventilation 
(C) in conscious mice up to 2 hr after intraperitoneal injections of saline or zymosan (500 mg/kg; n = 5 
per group). Data are presented as means ± SE. * Significant difference (p < 0.05).
Figure 5.  Zymosan-induced systemic inflammation is accompanied by increased carotid body chemoaf-
ferent activity. A, Raw data illustrating changes in the carotid sinus nerve chemoafferent activity recorded 
in the in vitro carotid body/carotid sinus nerve preparations taken 3 hr after intraperitoneal injections of 
saline (control) or zymosan (500 mg/kg). B–D, Population data [n = 7 mice per group] demonstrating that 
the development of systemic inflammation in response to zymosan leads to higher baseline (A), hypoxia 
(B) and cyanide induced (C) chemoafferent discharge. C and D, Data are shown as absolute increases 
from the baseline level of activity. Data are presented as means ± se. *Significant difference (p < 0.05).
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neural control are detected by profound changes in heart rate 
variability (4, 8).
CONCLUSION
Perturbations of autonomic control mechanisms are likely 
to play a key role at the onset of critical illness (8). The early 
detection of blood-borne DAMPs and PAMPs by the carotid 
chemoreceptors and the consequent inflammasome-depen-
dent cytokine-induced activation of the peripheral chemo-
reflex are likely to play a pivotal role in triggering autonomic 
dysregulation. Understanding how afferent function is altered 
during systemic inflammation and sepsis may provide novel 
therapeutic opportunities and/or monitoring modalities (33) 
to explore.
REFERENCES
 1. Cinel I, Opal SM: Molecular biology of inflammation and sepsis: A 
primer. Crit Care Med 2009; 37:291–304
 2. Guarda G, So A: Regulation of inflammasome activity. Immunology 
2010; 130:329–336
 3. Tracey KJ: Physiology and immunology of the cholinergic antiinflam-
matory pathway. J Clin Invest 2007; 117:289–296
 4. Korach M, Sharshar T, Jarrin I, et al: Cardiac variability in critically ill 
adults: influence of sepsis. Crit Care Med 2001; 29:1380–1385
 5. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of 
the systemic inflammatory response syndrome (SIRS). A prospective 
study. JAMA 1995; 273:117–123
 6. Godin PJ, Fleisher LA, Eidsath A, et al: Experimental human 
endotoxemia increases cardiac regularity: Results from a prospective, 
randomized, crossover trial. Crit Care Med 1996; 24:1117–1124
 7. Marshall JM: Peripheral chemoreceptors and cardiovascular regula-
tion. Physiol Rev 1994; 74:543–594
 8. Godin PJ, Buchman TG: Uncoupling of biological oscillators: A com-
plementary hypothesis concerning the pathogenesis of multiple organ 
dysfunction syndrome. Crit Care Med 1996; 24:1107–1116
 9. Annane D, Trabold F, Sharshar T, et al: Inappropriate sympathetic acti-
vation at onset of septic shock: A spectral analysis approach. Am J 
Respir Crit Care Med 1999; 160:458–465
 10. Zapata P, Larraín C, Reyes P, et al: Immunosensory signalling by 
carotid body chemoreceptors. Respir Physiol Neurobiol 2011; 
178:370–374
 11. Lamkanfi M, Malireddi RK, Kanneganti TD: Fungal zymosan and 
mannan activate the cryopyrin inflammasome. J Biol Chem 2009; 
284:20574–20581
 12. Ackland GL, Gutierrez Del Arroyo A, Yao ST, et al: Low-molecular-
weight polyethylene glycol improves survival in experimental sepsis. 
Crit Care Med 2010; 38:629–636
 13. Volman TJ, Goris RJ, van der Jagt M, et al: Organ damage in zymo-
san-induced multiple organ dysfunction syndrome in mice is not 
mediated by inducible nitric oxide synthase. Crit Care Med 2002; 
30:1553–1559
 14. Trapp S, Aller MI, Wisden W, et al: A role for TASK-1 (KCNK3) chan-
nels in the chemosensory control of breathing. J Neurosci 2008; 
28:8844–8850
 15. Kummer JA, Broekhuizen R, Everett H, et al: Inflammasome compo-
nents NALP 1 and 3 show distinct but separate expression profiles 
in human tissues suggesting a site-specific role in the inflammatory 
response. J Histochem Cytochem 2007; 55:443–452
 16. Descamps D, Le Gars M, Balloy V, et al: Toll-like receptor 5 (TLR5), 
IL-1β secretion, and asparagine endopeptidase are critical factors 
for alveolar macrophage phagocytosis and bacterial killing. Proc Natl 
Acad Sci USA 2012; 109:1619–1624
 17. Mizutani N, Nabe T, Yoshino S: Complement C3a regulates late asth-
matic response and airway hyperresponsiveness in mice. J Immunol 
2009; 183:4039–4046
 18. Brealey D, Karyampudi S, Jacques TS, et al: Mitochondrial dysfunc-
tion in a long-term rodent model of sepsis and organ failure. Am J 
Physiol Regul Integr Comp Physiol 2004; 286:R491–R497
 19. Trapp S, Tucker SJ, Gourine AV: Respiratory responses to hypercap-
nia and hypoxia in mice with genetic ablation of Kir5.1 (Kcnj16). Exp 
Physiol 2011; 96:451–459
 20. Rong W, Gourine AV, Cockayne DA, et al: Pivotal role of nucleotide 
P2X2 receptor subunit of the ATP-gated ion channel mediating venti-
latory responses to hypoxia. J Neurosci 2003; 23:11315–11321
 21. Kumar P, Bin-Jaliah I: Adequate stimuli of the carotid body: More than 
an oxygen sensor? Respir Physiol Neurobiol 2007; 157:12–21
 22. Del Rio R, Moya EA, Parga MJ, et al: Carotid body inflammation and 
cardiorespiratory alterations in intermittent hypoxia. Eur Respir J 
2012; 39:1492–1500
 23. Gross O, Thomas CJ, Guarda G, et al: The inflammasome: An inte-
grated view. Immunol Rev 2011; 243:136–151
 24. Sutterwala FS, Ogura Y, Flavell RA: The inflammasome in pathogen 
recognition and inflammation. J Leukoc Biol 2007; 82:259–264
 25. Shu HF, Wang BR, Wang SR, et al: IL-1beta inhibits IK and increases 
[Ca2+]i in the carotid body glomus cells and increases carotid sinus 
nerve firings in the rat. Eur J Neurosci 2007; 25:3638–3647
Figure 6.  Single-unit analysis of carotid sinus nerve discharge.  
A, Discharge frequency of individual fibers only increases in controls. Data 
are presented as mean ± SE. * Significant difference (p < 0.01; [n = 7 
mice per group]). B, More single units are recruited in preparations taken 
from zymosan-treated mice during normoxic (* p = 0.0001) and hypoxic  
(# p = 0.0001) conditions (n = 7 mice per group).
Ackland et al
e92 www.ccmjournal.org June 2013 • Volume 41 • Number 6
 26. Fernández R, González S, Rey S, et al: Lipopolysaccharide-induced 
carotid body inflammation in cats: Functional manifestations, 
histopathology and involvement of tumour necrosis factor-alpha. Exp 
Physiol 2008; 93:892–907
 27. Hellwig-Bürgel T, Rutkowski K, Metzen E, et al: Interleukin-1beta and 
tumor necrosis factor-alpha stimulate DNA binding of hypoxia-induc-
ible factor-1. Blood 1999; 94:1561–1567
 28. Jacono FJ, Peng YJ, Nethery D, et al: Acute lung injury augments 
hypoxic ventilatory response in the absence of systemic hypoxemia. J 
Appl Physiol 2006; 101:1795–1802
 29. Tang GJ, Kou YR, Lin YS: Peripheral neural modulation of endotoxin-
induced hyperventilation. Crit Care Med 1998; 26:1558–1563
 30. Schmidt H, Müller-Werdan U, Hoffmann T, et al: Autonomic dys-
function predicts mortality in patients with multiple organ dysfunc-
tion syndrome of different age groups. Crit Care Med 2005; 33: 
1994–2002
 31. Schmidt H, Hoyer D, Hennen R, et al: Autonomic dysfunction 
predicts both 1- and 2-month mortality in middle-aged patients with mul-
tiple organ dysfunction syndrome. Crit Care Med 2008; 36: 967–970
 32. Taylor EW, Jordan D, Coote JH: Central control of the cardiovascular 
and respiratory systems and their interactions in vertebrates. Physiol 
Rev 1999; 79:855–916
 33. Cooke WH, Rickards CA, Ryan KL, et al: Autonomic compensation 
to simulated hemorrhage monitored with heart period variability. Crit 
Care Med 2008; 36:1892–1899
